Our Portfolio

Curadim Pharma Co., Ltd.

Outline R&D of pharmaceutical products
Website

http://curadim.co.jp/

Industry Health/medicine
Commercialization stage Early stage

Provided Support

  • Promote the creation of a new model case by providing support for spin-out ventures from the establishment stage in order to contribute to the development of early stage seeds from domestic pharmaceutical companies
  • Aim to promote open innovation by mobilizing resources and technological research in the pharmaceutical industry
  • Contribute towards solving societal issues by providing innovative pharmaceutical products for intractable diseases with high unmet medical needs
Authorized Investment 1 billion yen (maximum)
Announcement Date Aug 04, 2016
Investment Structure

Related Press Releases

Aug 04, 2016
INCJ announces drug candidate licensing, investment in Curadim Pharma Co., Ltd. New company to develop new drugs for treatment of intractable diseases
HOME
About Us
Our Business
Newsroom
Our Investments